D2R is mainly expressed in lactotrophs, but has been localized to all anterior pituitary cell types (3), leading to off-label evaluation of cabergoline, bromocriptine, and quinagolide as DA treatment in other pituitary tumors. The gene discussed is DRD2; the disease is pituitary tumor.